Search results
This updated guideline provides recommendations for the care and management of people with or at risk for diabetes mellitus at every stage, including prevention, diagnosis, and treatment.
- Endorsed Clinical Guidance
After careful review, AACE may endorse clinical guidance...
- 2023 AACE Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm
It incorporates newer therapies and management approaches...
- Pituitary, Gonad, Adrenal and Neuroendocrine
These six case discussions present clinical vignettes to...
- Archived Guidance Documents
2018 Position Statement on Integration of Insulin Pumps and...
- Documents in Development
Type 2 Diabetes. In process. Guideline Postmenopausal...
- Frequently Asked Questions
The Clinical Practice Guidelines Oversight Committee,...
- Cardiometabolic and Lipids
It provides guidance on screening, risk assessment, and...
- Bone and Parathyroid
This guideline provides recommendations to reduce a person's...
- Endorsed Clinical Guidance
18 mar 2024 · Treatment of patients with type 2 diabetes mellitus includes education, evaluation for micro- and macrovascular complications, attempts to achieve near normoglycemia, minimization of cardiovascular and other long-term risk factors, and avoidance of drugs that can exacerbate abnormalities of insulin or lipid metabolism.
4 gru 2020 · Glycemic control is assessed by the A1C measurement, continuous glucose monitoring (CGM), and self-monitoring of blood glucose (SMBG). A1C is the metric used to date in clinical trials demonstrating the benefits of improved glycemic control.
1 paź 2021 · Blood pressure should be measured at all clinic visits for patients with diabetes, and treatment is more aggressive than for patients without diabetes. If diastolic blood pressure is ≥ 90 mmHg or systolic blood pressure is ≥ 140 mmHg on two visits, antihypertensive therapy should be instituted ( Tables 6 and 9 ).
14 mar 2023 · Type 2 diabetes is usually diagnosed using the glycated hemoglobin (A1C) test. This blood test indicates your average blood sugar level for the past two to three months. Results are interpreted as follows: Below 5.7% is normal. 5.7% to 6.4% is diagnosed as prediabetes. 6.5% or higher on two separate tests indicates diabetes.
Optimal glycemic control is fundamental to the management of diabetes. Both fasting and postprandial plasma glucose levels correlate with the risk of complications and contribute to the measured glycated hemoglobin (A1C) value. Glycemic targets should be individualized based on the individual's frailty or functional dependence and life expectancy.
General treatment of diabetes mellitus for all patients involves lifestyle changes, including diet and exercise. Appropriate monitoring and control of blood glucose levels is essential to prevent complications of diabetes. (See also Diabetes Mellitus.)
